Stimulation of prostaglandin G/H synthase-2 expression by arachidonic acid monoxygenase product, 14,15-epoxyeicosatrienoic acid

FEBS Lett. 1997 Oct 27;416(3):269-72. doi: 10.1016/s0014-5793(97)01227-1.

Abstract

The relationship between arachidonic acid (AA) mobilization and transcription of immediate-early genes, particularly of prostaglandin G/H synthase-2 (PGHS-2), in intestinal crypt epithelial cells was analyzed. PGHS-2 mRNA and protein synthesis were stimulated by its own substrate, AA; actinomycin D, a transcription inhibitor, prevented the AA-induced increase in PGHS-2 mRNA. Eicosatetraynoic acid, an inhibitor of AA utilization, significantly reduced PGHS-2 mRNA synthesis elicited by AA. Inhibitors of cytochrome P450 monoxygenases, ketoconazole and miconazole, also prevented PGHS-2 mRNA synthesis in a dose-dependent manner. Phenyl chalcone oxide, an epoxide hydrolase inhibitor, potentiated AA-induced PGHS-2 mRNA synthesis. Of the four regioisomers of arachidonic acid epoxides, only 14,15-epoxyeicosatrienoic acid elicited the expression of PGHS-2 in intestinal crypt epithelial cells. This is the first direct evidence of stimulation of an immediate-early gene product, specifically PGHS-2, by an AA epoxygenase metabolite, 14,15-epoxyeicosatrienoic acid, as well as of a heterologous regulation of PGHS-2 synthesis by these monoxygenase products.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5,8,11,14-Eicosatetraynoic Acid / pharmacology
  • 8,11,14-Eicosatrienoic Acid / analogs & derivatives*
  • 8,11,14-Eicosatrienoic Acid / pharmacology
  • Animals
  • Aryl Hydrocarbon Hydroxylases*
  • Cell Line
  • Cyclooxygenase 2
  • Cytochrome P450 Family 2
  • Dactinomycin / pharmacology
  • Gene Expression Regulation, Enzymologic / drug effects*
  • Intestinal Mucosa
  • Isoenzymes / biosynthesis*
  • Isomerism
  • Kinetics
  • Mixed Function Oxygenases*
  • Oxygenases / metabolism
  • Prostaglandin-Endoperoxide Synthases / biosynthesis*
  • RNA, Messenger / biosynthesis
  • Rats
  • Transcription, Genetic / drug effects*

Substances

  • Isoenzymes
  • RNA, Messenger
  • 5,8,11,14-Eicosatetraynoic Acid
  • Dactinomycin
  • 14,15-epoxy-5,8,11-eicosatrienoic acid
  • Mixed Function Oxygenases
  • Oxygenases
  • Aryl Hydrocarbon Hydroxylases
  • Cyp2b19 protein, mouse
  • Cytochrome P450 Family 2
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • 8,11,14-Eicosatrienoic Acid